top of page
Why Dose Matters, Every Time.
The Dosisphere-01 clinical trial for personalized theranostics helped improve life expectancy by 150% and increased the number of patients who could be treated by potentially curative surgery by 800%. The trial results indicated that it was deemed unethical to continue.
Read more about the trial. We see the power of personalized dosimetry and we see it as our mission to make it available to all who need it.
ABOUT OUR COMPANY
TeleDaaS is a pioneering medical practice providing Dosimetry-as-a-Service from the Bench to the Bedside
Dose matters, and TeleDaaS envisions a future where every physician, hospital, and clinical trial, no matter the scale or location, can access the life-saving power of advanced dosimetry so that every patient can receive the right dose, every time.
800%
Increase in patients that could be downstaged to curative intent surgery
150%
Increased life expectancy in Dosisphere-01 trial
The Right Dose, Faster
Elevate patient care with our advanced dosimetry support, revolutionize radiotherapy for improved outcomes, and empower your team to transform healthcare with us.
